Home » Toshiba Enters Biochip Market With Novel Chip to Manage Hepatitis C

Toshiba Enters Biochip Market With Novel Chip to Manage Hepatitis C

Oct 18, 2001

NEW YORK, Oct. 18 – Toshiba has entered the biochip arena by developing a DNA chip that it says can help researchers develop individual treatments for patients with hepatitis C, the company said on Thursday. 

The company said it planned to start marketing its pilot SNP-detection chip in fiscal 2002, which kicks off in April. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.